The OIE develops normative documents relating to rules that Members can use to protect themselves from diseases. By applying these rules, Members can be assured that their measures do not represent unjustified sanitary barriers, because the OIE normative documents enjoy recognition as 'international standards' under the agreements of the WTO.
There are currently 27 OIE Reference Laboratories for aquatic animal diseases. Under the guidance of an expert whose competence is recognised internationally, they function as centres of expertise and standardisation of diagnostic techniques. Additionally, they may provide scientific and technical training for personnel from Member Countries and Territories and coordinate scientific and technical studies in collaboration with other laboratories or organisations.
This paper describes the development of the latest versions of the OIE Aquatic Animal Health Code (Aquatic Code) and the OIE Manual of Diagnostic Tests for Aquatic Animals (Aquatic Manual), and how both standards assist in preventing and managing aquatic animal disease emergencies. Since the publication of the first editions of these standards in 1995, several editions of each document have been produced, but the changes made over the last three years in particular have significantly altered the scope and format of those standards and increased their usefulness. The role of OIE Reference Laboratories in the diagnosis of aquatic animal diseases will be explained.
The OIE standards for aquatic animals
The standards for aquatic animals (the Aquatic Code and the Aquatic Manual) are prepared by the Aquatic Animals Commission with the assistance of internationally renowned experts, individually, or through ad hoc groups. The views of Member Countries and Territories are systematically sought through the circulation of draft and revised texts to OIE Member Delegates. Delegates are then expected to seek the comments of the relevant national experts before informing the OIE of their country' s response. The standards are finally adopted by the OIE International Committee at the annual General Assembly of all Delegates from all Member Countries and Territories.
The International Committee is the highest authority of the OIE. It comprises the Delegates of all Member Countries and Territories. The General Session of the International Committee lasts five days and is held every year during the last week of May in Paris, France. Voting by Delegates within the International Committee respects the democratic principle of 'one country, one vote'. However, most decisions are made on the basis of consensus, avoiding the need for the casting of votes by its Delegates.
The value of the OIE standards is twofold:
-the measures published in the standards are the result of consensus among the veterinary authorities of OIE Members -the standards constitute a reference within the SPS Agreement for international standards for animal health and zoonoses.
The OIE Aquatic Animal Health Code
The aim of the Aquatic Code is to assure the sanitary safety of international trade in aquatic animals (fish, molluscs and crustaceans) and their products. This is achieved through the detailing of health measures to be used by veterinary or other competent authorities of importing and exporting countries. These measures are designed to minimise the transfer of agents that are pathogenic for aquatic animals while ensuring that unjustified sanitary barriers are avoided. The Aquatic Code makes reference only to the aquatic animal health situation in the exporting country, assuming that either the disease is not present in the importing country or is the subject of a control or eradication programme. Therefore, when determining its import measures, an importing country should do so in a way that is consistent with the principle of national treatment and the other provisions of the SPS Agreement.
The Aquatic Code is updated regularly, and a new edition is published each year, both in hard copy and on-line. At the time of writing, the latest edition is from 2007 (13) . Part 1 of the Aquatic Code contains general provisions for aquatic animal health, while Part 2 details recommendations applicable to specific diseases. Appendices on blood sampling and vaccination and on inactivation of pathogens are contained in Part 3, and Part 4 provides model international aquatic animal health certificates. The next section describes in more detail how the provisions of Parts 1 and 2 can assist in aquatic animal disease prevention and control.
Part 1 of the Aquatic Code: General provisions

Section 1.1 General definitions
This section provides definitions of the terms or expressions used. It is important to realise that these definitions are contextual, i.e. 'for the purpose of the Aquatic Code', and not stand-alone definitions of general applicability. The need to define terms that on the surface appear straightforward (e.g. 'disease', 'infection') arose with the formal recognition in 1998 of the OIE standards as reference documents within the SPS Agreement. It is also noteworthy that not all of the definitions in the Aquatic Code are identical to those used in the OIE Terrestrial Animal Health Code (Terrestrial Code). Whilst harmonisation of both Codes is an ongoing priority for the OIE, biological differences between terrestrial and aquatic animals sometimes warrant different definitions. An example is the definition of 'zone' which in the Aquatic Code -but not in the Terrestrial Code -refers to water catchments.
Section 1.2 Notification systems
Chapter 1.2.1 in Section 1.2 describes notification systems, commencing with the statement that 'Countries shall make available to other countries, through the OIE, whatever information is necessary to minimise the spread of aquatic animal diseases and their aetiological agents and to assist in achieving better world-wide control of these diseases'. This important ground rule is followed by detailed reporting requirements for OIE Member Countries and Territories. These rules specify the disease events that must be reported to the OIE within 24 hours ('immediate' notification). The overall purpose of these provisions is transparency in the animal health situation worldwide. While the necessity for such transparency is particularly obvious in clinical outbreaks of disease, this section of the Aquatic Code points out that the presence of an infectious agent, even in the absence of clinical disease, should also be reported. Chapter 1.2.2 in Section 1.2 presents the criteria for including an aquatic animal disease on the OIE list of notifiable diseases. These criteria are consistent with those used in the Terrestrial Code. Diseases proposed for listing must meet all of the relevant parameters under the topics 'consequences', 'spread' and 'diagnosis'. It is important to note that a disease may be listed if it has been shown to, or scientific evidence indicates that it is likely to, negatively affect wild aquatic animal populations that are an asset worth protecting for economic or ecological reasons. This means that primary production losses in aquaculture are not the only consequence that would support a listing.
For some new and emerging diseases, it may not be possible to conduct such a full assessment against the listing criteria, because the scientific information is not yet available. For such diseases, this chapter provides a shorter, less stringent set of listing criteria to facilitate their listing and enable information on the occurrence of these diseases to be collected. It is understood that after an appropriate time period, the Aquatic Animals Commission will re-assess the listing of this disease, with a view to either conducting a full assessment, or -if the problem has declined -proposing that the disease be delisted. 
Section 1.3 Obligations and ethics in international trade
The first chapter in Section 1.3 begins by stating that the aquatic animal health situation in the exporting country, in the transit country or countries, and in the importing country should be considered before determining the requirements that have to be met for trade. The chapter then continues with responsibilities of the importing country, for example, that the import requirements included in the international aquatic animal health certificate should assure that commodities introduced into the importing country comply with the national appropriate level of protection (ALOP), and that importing countries should restrict their requirements to those justified by this ALOP. If these are stricter than the OIE standards, guidelines and recommendations, then they should be based on an import risk analysis (see description in Section 1.4 below). Also detailed are the responsibilities of the exporting country, notably, that it must be prepared to supply certain information to importing countries on request. Responsibilities in the case of an incident occurring after importation are also laid down.
The second chapter in Section 1.3 specifies certification procedures.
Section 1.4 Risk analysis
The importation of animals and animal products, whether of aquatic or terrestrial origin, involves a degree of disease risk to the importing country, therefore, in Section 1.4, the Aquatic Code describes the principles of conducting risk analyses. The principal aim of import risk analysis is to provide importing countries with an objective and defensible method of assessing the disease risks associated with the importation of animals, animal products, animal genetic material, feedstuffs, biological products and pathological material. The principles and methods are the same whether the commodities are derived from aquatic or from terrestrial animal sources. The analysis should be transparent. This is necessary so that the exporting country is provided with clear reasons for the imposition of import conditions or any refusal to import. Given the difficulty of establishing and maintaining freedom from a particular disease for an entire country, especially for diseases whose entry is difficult to control, there may be benefits to some countries in establishing and maintaining a subpopulation with a distinct aquatic animal health status. Subpopulations may be separated by natural or artificial geographical barriers or, in certain situations, by the application of appropriate management practices.
In May 2007, the OIE International Committee adopted a revised version of Chapter 1.4.4 on zoning and compartmentalisation. Zoning and compartmentalisation are procedures implemented by a country to define subpopulations of distinct aquatic animal health status for the purpose of disease control or international trade. Compartmentalisation applies to a subpopulation when management practices related to biosecurity are the defining factors, while zoning applies when a subpopulation is defined on a geographical basis. In practice, spatial considerations and good management play important roles in the application of both concepts.
Zoning and compartmentalisation may not be applicable to all diseases, but the OIE will develop separate requirements for each disease for which the application of zoning or compartmentalisation is considered appropriate. More detailed information on how compartmentalisation may assist in disease control is provided elsewhere in this publication (14) .
More information on import risk analysis in general is contained in the OIE Handbook on Import Risk Analysis for Animals and Animal Products which comes in two volumes, the first providing an introduction and details of qualitative risk analysis (7) , and the second providing detailed information on quantitative risk analysis (8) .
Section 1.5 Import/export procedures
This section describes aquatic animal health measures applicable before departure, during transit, and on arrival. Chapter 1.5.1 makes recommendations for transport and provides detailed technical requirements regarding disinfection of transporters, treatment of transportation water, and discharge of infected water. Chapter 1.5.2 spells out aquatic animal health measures applicable before and at departure, for example, each country should only authorise the export of live aquatic animals and aquatic animal products if they are correctly identified and have been inspected according to the procedures outlined in the Aquatic Code and Aquatic Manual. Chapter 1.5.3 describes aquatic animal health measures applicable during transit, Chapter 1.5.4 provides details of the responsibilities of frontier posts in the importing country, and Chapter 1.5.5 describes aquatic animal health measures applicable on arrival. The latter includes, for example, guidance that an importing country should only accept into its territory, live aquatic animals that have been examined by a member of the personnel of the competent authority of the exporting country or a certifying official approved by the importing country, and that are accompanied by an international aquatic animal health certificate. Finally, Chapter 1.5.6 recommends measures concerning international transport of aquatic animal disease agents and pathological material. It goes into details on packaging and documentation for transport, with the aim of reducing the risk of accidental release of aquatic animal pathogens during international transport of packaged materials.
Section 1.6 Contingency plans
A number of diseases are regarded as posing a potential threat to aquaculture as well as to wild stocks of aquatic animals in some countries. The introduction of such diseases into countries declared free from these diseases or into countries with an established control system and eradication programme for such diseases, may result in significant losses. To diminish such losses, the veterinary administration or other competent authority responsible for aquatic animal health may need to act quickly and should develop contingency plans before such events occur. This short section, which contains only one chapter, provides guidelines for contingency planning. More information on contingency planning can be found in another paper in this publication (4).
Section 1.7 Fallowing
Discontinuation of an agricultural pursuit (for example, by crop rotation or by fallowing) is commonly recognised to be of value in resting or restoring the local environment.
In the aquatic environment, fallowing can also assist in breaking re-infection cycles by reducing the amount of a disease agent on a site, simply through removing its host. Consequently, fallowing is often carried out as a regular disease management measure in aquaculture, especially prior to the introduction of new populations of aquatic animals into a previously used site. This section, which also contains just one chapter, provides guidelines for fallowing in aquaculture.
Part 2 of the Aquatic Code: Recommendations applicable to specific diseases
Part 2 contains recommendations applicable to specific diseases of fish, molluscs and crustaceans. Until 2005, those recommendations focused almost entirely on demonstrating freedom from infection with the diseases listed. The requirements that needed to be fulfilled before a country, zone or individual aquaculture establishment could be declared free were largely identical for each listed disease. They required, for example, two years of targeted surveillance and laboratory testing of a prescribed number of animals, irrespective of the nature of the disease and the epidemiological circumstances.
In May 2003, the International Committee adopted a new Aquatic Manual chapter on surveillance requirements for declaration of freedom from infection. This chapter suggested that disease-specific information be used to underpin sampling and surveillance schemes and consequently the provisions for declaration of freedom from listed diseases. It also provided for alternative pathways to declaration of freedom, taking into account historical freedom as well as the absence of susceptible species. With the adoption of that chapter, a major overhaul of Part 2 of the Aquatic Code was warranted.
Moreover, prior to 2005, the disease chapters in the Aquatic Code did not offer much advice regarding protective measures in international trade in susceptible animals or their products, apart from a general recommendation that the importing country should require a health certificate from the exporting country. The chapters did not suggest any disease-specific measures to manage the risk associated with the importation of certain commodities. Neither did they reflect the realities of trade, such as the fact that more than 90% (45 million tonnes [live weight equivalent]) of world fish trade is in processed fish (2), some of which can probably be traded quite safely with few -if any -sanitary measures.
In 2004, the Aquatic Animals Commission, in close consultation with the OIE Terrestrial Animal Health Standards Commission, developed a template on which to base individual disease chapters for the Aquatic Code. This approach was adopted by the OIE International Committee in 2004 (6) . Apart from addressing the issues around commodities and declaration of freedom as described above, the new template also introduced the concept of compartments in addition to zones for establishing and maintaining subpopulations of aquatic animals with a distinct health status (see above).
The International Committee adopted three chapters in the new format in 2005 (one for a disease of fish, one for a disease of molluscs and one for a disease of crustaceans) (9) , and in 2006, most other fish and mollusc disease chapters were adopted in the new format (10) . By mid 2007, new versions of all disease chapters (except those on de-listed diseases) for fish, mollusc and crustaceans had been adopted (12) and were included in the tenth edition (2007) of the Aquatic Code (13) . Modifications of a technical nature are made on an ongoing basis to continuously improve the accuracy and applicability of those chapters. (Chapters on diseases that no longer met the listing criteria were maintained if they were still considered of some importance for international tradethese chapters will also be updated over time.)
All disease chapters are now presented in a consistent format, and the recommendations in each of the disease chapters are designed to minimise the risk of the disease under consideration being introduced and established in the importing country, taking into account the nature of the traded commodity (e.g. live animals or dead product), its intended purpose (e.g. for aquaculture or for human consumption) and the aquatic animal health status of the exporting country (declared free or not declared free). This means that, correctly applied, the recommendations ensure that the intended importation can take place with an optimal level of animal health security, incorporating the latest scientific findings and available techniques. 
Article 3 Commodities Articles 7 to 12 Recommendations for trade
Essentially, there are two broad categories of traded commodities: the ones that are considered 'safe' for trade, and the ones for which a risk analysis is recommended. For the latter, specific measures are suggested wherever possible.
When authorising import or transit of 'safe' commodities, competent authorities should not require any conditions relating to the disease in question, regardless of the status of the exporting country, zone or compartment for that disease or its intended end-use. Typically, these commodities are 'sterile' products derived from the susceptible species, that is, products that have been treated in such a way that the infective agent has been inactivated. However, for some diseases (for example some mollusc diseases caused by parasites), gametes, eggs and larvae of the susceptible species may also be safe to trade, regardless of their origin or the intended end-use. For some diseases, it is also possible to list as 'safe' any commodities derived from host species 'known not to be susceptible' (as opposed to 'not known to be susceptible'). For example, regarding the molluscan infection with Marteilia refringens, the importation of all commodities from the Pacific oyster Crassostrea gigas -including the live animal -from anywhere (including countries that are not declared free of this disease) is considered safe.
Another group of commodities that can be assumed to be safe for trade -regardless of where they originate -are those that are destined for human consumption and have been prepared and packaged for direct retail trade. This usually means chemically preserved products, but for some diseases, chilled or frozen eviscerated fish, chilled or frozen fillets or cutlets and dried eviscerated fish are also considered safe.
For the second, bigger group of commodities, i.e. those for which some form of analysis is recommended, specific guidance is provided in Articles 7 to 12. These recommendations for disease-specific risk management measures depend on the status of the exporting country, zone or compartment for that disease and take into account the intended end-use for the traded commodity, for example, release into aquaculture, or direct human consumption, the latter being generally regarded as of lower risk.
For example, for the importation of live aquatic animals, for any purpose, from countries, zones or compartments declared free of koi herpesvirus disease (KHVD), Article 7 recommends that the importing country require a health certificate from the exporting country that confirms that the place in which the fish were produced has been declared free of KHVD. This is the only measure recommended.
If the live fish are intended for aquaculture purposes and originate from a place not declared free of KHVD, Article 8 applies and recommends that the importing country assess the risk. This article further suggests suitable risk mitigation measures, for example, the direct delivery to, and lifelong holding of the consignment in, biosecure facilities for continuous isolation from the local environment. Also, it is recommended that all effluent and waste material from the processing procedure be treated in a manner that ensures inactivation of KHV.
If these live animals (from a place not declared free of KHVD) were intended for processing for human consumption (Article 9), it is recommended that they be delivered directly to, and held in, quarantine facilities before being slaughtered and processed into one of the 'safe' products listed earlier in Article 3 (or other products authorised by the competent authority). All effluent and waste material from the processing procedure will still need to be treated in a manner that ensures inactivation of KHV. Article 10 has similar provisions that apply when the live animals are intended for use in animal feed, or for agricultural, industrial or pharmaceutical use.
Acknowledging that KHVD may be transmitted even by dead product derived from infected species, the recommendation for the importation of product from countries, zones or compartments not declared free of KHVD (Article 12) is the direct delivery into, and holding of the consignment in, biosecure/quarantine facilities before being processed to become one of the 'safe' products listed in Article 3 (or other products authorised by the competent authority). All effluent and waste material will need to be treated in a manner that ensures inactivation of KHV. If the dead product is from a place declared free of KHVD (Article 11), it is recommended that the importing country require a health certificate from the exporting country that attests that the place in which the fish were produced has been declared free of KHVD. This is the only measure recommended. Table I summarises the various recommendations for trade in commodities derived from susceptible species.
As well as the categories of species already covered (the species that are known to be susceptible and those that are known not to be susceptible) there is a third categoryspecies that are not known to be susceptible, i.e. they may be, but it is not known for certain. For the importation of a live commodity of this type of species from a place not declared free of KHVD, a risk analysis is recommended only if the species could reasonably be expected to be a potential KHV vector.
Article 4 Disease-free country
This Article describes the requirements for self-declaration of country freedom from the disease under consideration. In general, four different pathways are described:
-absence of susceptible species -historical freedom -targeted surveillance with negative results (to be underpinned with scientifically based, disease-specific surveys)
-regaining freedom after an outbreak in a previously free country.
This constitutes a graded, risk-based approach. For example, where there are no susceptible species, there is no need for targeted surveillance (indeed, the value of targeted surveillance in non-susceptible species is difficult to imagine!). The four different pathways are described in more detail below.
Absence of susceptible species
For the purpose of self-declaration of freedom following this pathway, susceptible species are all those species listed in Article 2. However, the Aquatic Code recognises that the absence of these species alone may not provide sufficient assurance to allow declaration of freedom from the disease in question. Rather, a set of defined basic biosecurity conditions must have been met continuously for a specified time period before such a declaration is made. These basic biosecurity conditions are defined in the Aquatic Code. They require, inter alia, that an early detection system (also defined) is in place that must include 'veterinarians or aquatic animal health specialists trained in recognising and reporting suspicious disease occurrence'. The pertinent definitions are shown in Appendix I.
The number of years for which these basic biosecurity conditions must have been met depends on the disease. Whilst two years is set as a default, the period may be longer or shorter, depending on the biology and life cycle of the agent and the susceptible species; the requirement for, and presence of, intermediate hosts; direct transmission and incubation periods; and the seasonality of the disease. For example, the mollusc disease caused by infection with Marteilia refringens is seasonal, therefore, the period for which basic biosecurity conditions must have been met is three years, as this is the optimal period for enabling cases to be detected.
For diseases with a large number and wide range of susceptible host species (for example, the fish diseases viral haemorrhagic septicaemia [VHS] and epizootic ulcerative syndrome, and the mollusc disease caused by infection with Perkinsus olseni), the pathway via 'absence of susceptible species' is not recommended.
Historical freedom
Two time periods are critical, first, the 'historical' period during which the disease has not been observed and second, that part of this period during which the basic 
Targeted surveillance
The third pathway (targeted surveillance with negative results) can be used for countries that would not meet the requirements of the first two pathways, e.g. countries in which the presence of subclinical infection is likely (i.e. countries in which susceptible species are present but conditions are not conducive to clinical expression of the disease). In such a situation, not only must the basic biosecurity conditions have been met for a number of years, but targeted surveillance for the disease agent in question must have been conducted for that period without detection of the agent.
As with the other pathways, there is a two-year default time period for biosecurity conditions and targeted surveillance; however, for some diseases, more specific time periods can be stipulated to take into account the nature of the disease. For the mollusc disease caused by infection with Marteilia refringens the time period for biosecurity measures is three years, but negative results from targeted surveillance must have been obtained for at least the last two of those three years; starting the targeted surveillance in the second year of the biosecurity measures ensures that new cases of infection with M. refringens are more likely to be detected.
The OIE Aquatic Manual provides guidance on how to design and conduct targeted surveillance. Besides the general guidelines in Chapter 1.1.4, there is also diseasespecific information contained in each of the disease chapters (see below). These disease-specific chapters provide information that is crucial for the design and conduct of a sampling and testing programme, e.g. seasonality of the infection, host species and tissue predilections, and the diagnostic specificity and sensitivity of screening tests.
Over time, it will be possible to provide disease-specific time periods in more and more disease chapters of the Aquatic Code, consistent with the epidemiological information becoming available in the corresponding disease chapters in the Aquatic Manual.
Regaining freedom
The provisions of the fourth pathway apply to those countries that were declared free but then detected the disease in question. In this case, historical freedom and absence of susceptible species cannot apply, so to regain disease-free status targeted surveillance is mandatory for a specified time period (default two: years) after the detection. In addition, before an area can recover its disease-free status, there are several other requirements to fulfil:
-declaration of the affected area as an infected zone -establishment of a buffer zone -implementation of measures such as removal and destruction of infected populations and use of appropriate disinfection methods -review and modification of the previously existing biosecurity conditions (after disease has been detected the newly reviewed biosecurity measures must be implemented for a substantial period of time before disease-free status can be regained (default period: two years).
However, it is possible to maintain part of the non-affected area as a free zone provided it meets the criteria of Article 5 of the pertinent disease chapter in the Aquatic Code (see below).
Article 5 Disease-free zone or compartment
This article provides the requirements for self-declaration of freedom for zones and compartments. Essentially, the same four pathways as for country freedom are described. The provisions for regaining freedom after the disease has been detected in a previously free compartment are still under development.
Article 6 Maintenance of status
This article provides the requirements for maintaining disease-free status in a country, zone or compartment. Generally, targeted surveillance may be discontinued provided that basic biosecurity conditions are continuously maintained. However, this does not apply where a free zone or compartment is located in an infected country or in all cases where conditions are not conducive to clinical expression of the disease; in such cases, targeted surveillance needs to be continued at a level determined on the basis of likelihood of infection.
The OIE Manual of Diagnostic Tests for Aquatic Animals
The aim of the Aquatic Manual is to provide a uniform approach to the diagnosis of the diseases listed in the Aquatic Code and of other diseases that may be of importance to international trade, so that the requirements for health certification in connection with trade in aquatic animals and aquatic animal products can be met. This is achieved through the detailing of pathogen identification methods that are suitable for the diagnosis of isolated cases of disease as part of national aquatic animal health surveillance or control programmes, or as part of a programme to underpin claims of freedom from a specific disease.
Although many publications exist on the diagnosis and control of aquatic animal diseases, the Aquatic Manual is a key document describing the methods that can be applied in aquatic animal health laboratories all over the world, thus increasing efficiency and promoting improvements in aquatic animal health worldwide. The requirements published in this Aquatic Manual are recognised as international standards by the WTO.
The Aquatic Manual is updated regularly, and a new edition is published every 2 to 3 years in hard copy and on-line (11) . More frequent updates (in highlighted format) are made to the on-line version. 
Part 2 of the Aquatic Manual
Part 2 contains recommendations applicable to specific diseases of fish, molluscs and crustaceans. Just like for the Aquatic Code, the template for disease-specific chapters for the Aquatic Manual was completely overhauled in preparation for the fifth edition (2006), so these chapters are now presented in a consistent format that links back to the corresponding chapters in the Aquatic Code. However, not surprisingly, some teething problems occurred; for example, not all the disease chapters contain the same level of detail. The OIE now engages a consultant editor to, inter alia, revise the disease chapter template as well as the actual disease chapters for improved clarity and consistency of content. This is being done in preparation for the next (sixth) hard-copy edition of the Aquatic Manual (due in 2009).
Section 1 of each chapter provides a case definition of the disease in question. The following Sections 2 to 6 of each chapter warrant some closer inspection regarding how they can assist in aquatic animal disease prevention and control.
Section 2 Design of surveillance programmes
This section provides information for the design of surveillance programmes. Subsections cover the following:
-agent factors (aetiological agent, agent strains, survival outside the host, stability)
-host factors (susceptible species and their stages, target organs and infected tissue, vectors)
-the disease pattern (occurrence and transmission mechanisms, prevalence, geographical distribution, mortality and morbidity, economic and/or production impact)
-control and prevention (vaccination, chemotherapy, immunostimulation, resistance breeding, restocking with resistant species, blocking agents, and general husbandry practices).
Information on susceptible species and disease pattern is crucial when a country wishes to declare itself free of a certain disease, regardless of which pathway is chosen. Information on the agent and prevention and control clearly assists in managing the disease.
Section 3 Diagnostic methods
As the 'core part' of each disease chapter, this section provides information on diagnostic methods for the disease in question. Its subsections are field diagnostic methods (usually a short description of clinical signs), clinical methods (including gross and microscopic pathology, electron microscopy and cytopathology) and agent detection and identification methods -usually by far the largest single subsection in each entire chapter.
The clinical signs expressed by fish, molluscs and crustaceans infected with the diseases listed in the Aquatic Code are rarely pathognomonic. Moreover, animals may be subclinically infected with the causative agents of these diseases, that is, they may not show any clinical signs. The only reliable approach for diagnosis of aquatic animal diseases lies, therefore, in the specific identification of the pathogens, using laboratory methods. These methods, which are suitable for the diagnosis of isolated cases of disease as part of national aquatic animal health surveillance or control programmes, form the main contents of the Aquatic Manual.
These agent detection and identification methods are further divided into direct detection methods (microscopic methods, agent isolation and identification through cell culture or artificial media, antibody-based antigen detection methods, molecular techniques) and indirect methods (serology). However, there is usually little information provided under indirect methods, due to the insufficient development of serological methodology and the resulting lack of acceptance of the detection of antibodies to pathogens in fish as a routine method for assessing the health status of fish populations. For diseases of fish, the validation of some serological techniques could arise in the near future, rendering the use of serology more widely acceptable for diagnostic purposes, but molluscs and crustaceans do not produce antibodies as a response to infection.
In earlier editions of the Aquatic Manual, the methods described for screening or diagnosis of fish diseases were based either on isolation of the pathogen followed by its specific identification, or on the demonstration of pathogen-specific antigens using an immunological detection method. However, in recent years, molecular techniques such as the polymerase chain reaction (PCR), DNA probes and in-situ hybridisation have been increasingly developed for these purposes.
The experiences of the last decade indicate that the PCR techniques will eventually supersede many of the classical direct methods of infectious agent detection. It is clear that in many laboratories, PCR is replacing virus isolation or bacteria cultivation for the detection of agents that are difficult or impossible to culture. There are several reasons for this trend, including the fact that virus isolation requires:
-the presence of replicating viruses -expensive cell culture and maintenance facilities -as long as several weeks to complete the diagnosis -special expertise, which is missing or diminishing today in many laboratories.
PCR assays have now become relatively inexpensive, safe and user-friendly tools in diagnostic laboratories. Where a PCR method has been standardised sufficiently to become widely and reliably available, it has been added to the more traditional methods in the Aquatic Manual.
Section 4 Rating of tests against purpose of use
This section provides a rating of some of the tests described in Section 3 against a specific purpose of use (surveillance, presumptive diagnosis, confirmatory diagnosis). For many fish diseases, histology -while recommended as a standard method for presumptive diagnosis -would not be recommended for surveillance. In general, the ratings are as follows:
-'recommended method for reasons of availability, utility, and diagnostic specificity and sensitivity'
-'standard method with good diagnostic sensitivity and specificity'
-'the method has application in some situations, but cost, accuracy, or other factors severely limit its application' -'presently not recommended for this purpose'.
Although few of the methods listed in the first two categories would have undergone formal standardisation and validation (see Chapters 1.1.2 and 1.2.3 in Part 1 of the Aquatic Manual), their routine nature and the fact that they have been used widely without dubious results make them acceptable. It is acknowledged, however, that these ratings are somewhat subjective, as ratings for suitability involve issues of reliability, sensitivity, specificity and utility.
For the most part, molecular methods for fish diseases are recommended for either direct detection of the pathogen in clinically diseased fish or for the confirmatory identification of a disease agent isolated using the traditional method. However, with a few exceptions, molecular techniques are currently not acceptable as screening methods to demonstrate the absence of a specific disease agent in a fish population for the purpose of health certification in connection with international trade of live fish or their products. There is a need for more validation of molecular methods for this purpose before they can be recommended in the Aquatic Manual.
Because of the general unavailability of the traditional pathogen isolation methods for mollusc and crustacean diseases, molecular techniques, particularly PCR, have increasingly supplemented the more traditional histological and tissue smear methods described in the Aquatic Manual, not only for diagnosis of clinical cases but also for screening programmes to demonstrate the absence of the specific disease agent for health certification purposes.
Section 5 Corroborative diagnostic criteria
This section provides corroborative diagnostic criteria for the definition of a suspect case and a confirmed case, respectively. For many of the diseases, these definitions are a combination of clinical parameters and laboratory test results, the latter referring back to Section 4 and the rating of tests against purpose of use. An example is shown in Appendix II for infectious salmon anaemia.
Section 6 Diagnostic/detection methods to declare freedom
This section recommends diagnostic or detection methods to declare freedom from the disease under consideration.
As for the corroborative diagnostic criteria, these criteria also should refer back to Section 4 and the rating of tests against purpose of use. Multi-agent disease syndromes are common in the aquatic environment and are increasingly described, particularly in crustacean hosts. Most crustacean viruses cannot be grown in cell culture, infectivity trials are therefore hampered severely, and it is difficult to ascertain which role -if anya particular infectious agent plays in the syndrome. This is far from being an academic or research problem; rather, it severely compromises the development of case definitions for disease reporting purposes and the development of control strategies.
OIE Reference Laboratories and Collaborating Centres
Currently, nearly half of the fish consumed as food worldwide originate in aquaculture rather than in the wild, compared to less than 10% in 1980, and while consumer demand for fish continues to climb worldwide, levels of capture from the wild have remained roughly stable since the mid 1980s (3). Therefore, there will be increasing pressure on aquaculture to meet the demand, and with increased production will come increased disease risks. These will arise not only through the intensification of culture but also through the switch to 'new' species (see above) and the translocation of live animals that have successfully been cultured in one part of the world to new destinations. The accompanying risk of disease transfer is well documented, but it appears that there is still not enough attention paid to preventing spread of such diseases. 
Mots-clés
Animal aquatique -Commerce international -Diagnostic -Norme -Organisation mondiale de la santé animale -Prophylaxie -Risque sanitaire -Santé des animaux aquatiques.
Terms displayed in italics are further defined in the Aquatic Animal Health Code (13) Basic biosecurity conditions means a set of conditions applying to a particular disease, and a particular zone or country, required to ensure adequate disease security, such as: a) the disease, including suspicion of the disease, is compulsorily notifiable to the Competent Authority; and b) an early detection system is in place within the zone or country; and c) import requirements to prevent the introduction of disease into the country or zone, as outlined in the Aquatic Code, are in place.
Early detection system means an efficient system for ensuring the rapid recognition of signs that are suspicious of a listed disease, or an emerging disease situation, or unexplained mortality, in aquatic animals in an aquaculture establishment or in the wild, and the rapid communication of the event to the Competent Authority, with the aim of activating diagnostic investigation with minimal delay. Such a system will include the following characteristics: a) broad awareness, e.g. among the personnel employed at aquaculture establishments or involved in processing, of the characteristic signs of the listed diseases and emerging diseases; b) veterinarians or aquatic animal health specialists trained in recognising and reporting suspicious disease occurrence; c) ability of the Competent Authority to undertake rapid and effective disease investigation; d) access by the Competent Authority to laboratories with the facilities for diagnosing and differentiating listed and emerging diseases.
Emerging disease means a newly recognised serious disease, the cause of which may or may not yet be established, that has the potential to be spread within and between populations, for example by way of trade in aquatic animals and/or aquatic animal products.
Appendix I
OIE Aquatic Animal Health Code definitions relating to the declaration of freedom from certain diseases
Appendix II
Corroborative diagnostic criteria for infectious salmon anaemia (ISA), as contained in the ISA chapter of the OIE Manual of Diagnostic Tests for Aquatic Animals
Corroborative diagnostic criteria
Reasonable grounds to suspect fish of being infected with ISAV are outlined in Section 5.a below. The Competent Authority shall ensure that, following the suspicion of fish on a farm being infected with ISAV, an official investigation to confirm or rule out the presence of the disease will be carried out as quickly as possible, applying inspection and clinical examination, as well as collection and selection of samples and using the methods for laboratory examination as described in Section 3. 
b) Definition of confirmed case
The following criteria in i) or ii) or iii) should be met for confirmation of ISA:
i) Mortality, clinical signs and pathological changes consistent with ISA (Section 3.a and b), and detection of ISAV by one or more of the following methods: a) isolation and identification of ISAV in cell culture from at least one sample from any fish on the farm as described in Section 3.c.ii b) detection of ISAV by RT-PCR by the methods described in Section 3.c.ii c) detection of ISAV in tissue preparations by means of specific antibodies against ISAV (e.g. IFAT on tissue imprints or fixed sections as described in Section 3.c.i)
ii) Isolation and identification of ISAV in cell culture from at least two independent samples from any fish on the farm tested on separate occasions as described in Section 3.c.ii
iii) Isolation and identification of ISAV in cell culture from at least one sample from any fish on the farm with corroborating evidence of ISAV in tissue preparations using either RT-PCR (Section 3.c.ii) or IFAT (Section 3.c.ii). Source: (11) .
